Hologic, Inc.: Breast Neoplasms trials
The registry lists 14 Breast Neoplasms studies with Hologic, Inc. as lead sponsor. 3 are open to participants now and 6 have results posted.
No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer PatientsRecruitingNCT06610539
- Magseed Pro(R)/ Sentimag(R) Gen3RecruitingNCT05142787Not applicable
- Magseed Enabled Long-Term Localization of Axillary Lymph NodesRecruitingNCT03796559Not applicable
- A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast BiopsyCompletedNCT04671329Not applicableResults posted
- Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard PaddleCompletedNCT03611543Results posted
- Brevera™ Breast Biopsy System Data Collection StudyCompletedNCT03456583Results posted
- A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy SystemCompletedNCT03300206Results posted
- SentiMag® Intraoperative Comparison in Breast CancerCompletedNCT02336737Not applicableResults posted
- Multicenter Hologic Tomosynthesis StudyCompletedNCT00971087Not applicableResults posted
- Breast Cancer Index (BCI) RegistryActive, not recruitingNCT04875351
- Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot StudyCompletedNCT01433640
- A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast AbnormalitiesCompletedNCT00990483Not applicable
- A Pilot Study - Comparison of Two Hologic 3D Mammography SystemsCompletedNCT00759447
- Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital MammographyCompletedNCT00754598Not applicable